PAG:NYSEPenske Automotive Group, Inc. Analysis
Data as of 2026-03-15 - not real-time
$145.93
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Penske Automotive Group is trading near its technical support level while technical momentum remains bearish, as indicated by a negative MACD and a low RSI suggesting oversold conditions. Fundamentally, the stock appears undervalued with a low price‑to‑earnings multiple and a solid dividend yield that is well covered by cash flow, reflected in a modest payout ratio. Recent earnings reports highlighted flat revenue and a slight earnings miss, yet the company announced strategic acquisitions and an increased dividend, which could bolster future earnings potential. Liquidity remains adequate with stable trading volume, and the beta below one points to lower market‑wide volatility relative to the broader index. However, the balance sheet is heavily leveraged, with debt‑to‑equity exceeding 150%, introducing financial risk if cash generation falters. The consumer‑cyclical nature of the auto retail sector adds medium‑level sector risk, especially amid uncertain vehicle demand. Geographic diversification across North America, Europe, and Asia spreads exposure but also brings medium currency and geopolitical considerations. Overall, the combination of attractive valuation, sustainable dividend, and recent strategic moves creates a nuanced picture: short‑term price pressure may persist, but medium‑ to long‑term fundamentals support a cautiously optimistic stance.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Oversold RSI indicating potential near‑term rebound
- Price at technical support providing downside cushion
- High dividend yield offering immediate income
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Undervalued valuation metrics relative to earnings
- Sustainable dividend supported by cash flow
- Strategic acquisitions expected to improve earnings growth
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Low PE and price‑to‑book ratios suggest long‑term value
- Diversified global footprint reduces reliance on any single market
- Consistent dividend policy provides compounding returns
Key Metrics & Analysis
Financial Health
Revenue Growth-3.10%
Profit Margin2.94%
P/E Ratio10.3
ROE17.05%
ROA4.62%
Debt/Equity158.09
P/B Ratio1.7
Op. Cash Flow$975.1M
Free Cash Flow$303.2M
Technical Analysis
TrendBearish
RSI27.9
Support$145.66
Resistance$179.34
MA 20$158.78
MA 50$161.34
MA 200$168.56
MACDBearish
VolumeStable
Fear & Greed Index72.88
Valuation
Target Price$181.67
Upside/Downside24.49%
GradeUndervalued
TypeValue
Dividend Yield3.84%
Risk Assessment
Beta0.71
Volatility32.11%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.